Table 4.
Comparisons of actionable genes between HER2-0 and HER2-low tumors.
Subtype | Gene | Mean | SD | Min | Max |
---|---|---|---|---|---|
HER2-0 (246) * |
AKT2 | 0.012 | 0.110 | 0 | 1 |
BRCA1 | 0.049 | 0.358 | 0 | 5 | |
BRCA2 | 0.098 | 0.412 | 0 | 4 | |
ERBB2 | 0.280 | 0.459 | 0 | 2 | |
ERBB3 | 0.004 | 0.064 | 0 | 1 | |
ESR1 | 0.008 | 0.128 | 0 | 2 | |
PIK3CA | 0.358 | 0.544 | 0 | 2 | |
PTEN | 0.008 | 0.128 | 0 | 2 | |
MDM2 | 0.037 | 0.188 | 0 | 1 | |
HER2-low (369) * |
AKT2 | 0.014 | 0.116 | 0 | 1 |
BRCA1 | 0.073 | 0.649 | 0 | 9 | |
BRCA2 | 0.171 | 1.154 | 0 | 14 | |
ERBB2 | 0.317 | 0.494 | 0 | 3 | |
ERBB3 | 0.003 | 0.052 | 0 | 1 | |
ESR1 | 0.008 | 0.090 | 0 | 1 | |
PIK3CA | 0.493 | 0.595 | 0 | 3 | |
PTEN | 0.008 | 0.090 | 0 | 1 | |
MDM2 | 0.038 | 0.191 | 0 | 1 |
* Subtype(subject number); HER2-0 and HER2-low are defined in the Section 4.